Skip to main content
BrainCited

Description

Sleep onset latency measurements across treatment groups indicate that valerian extract administration is associated with reduced time to fall asleep in the murine model. Dose-dependent trends suggest a potential sedative-hypnotic effect.

Cite This Figure

![Figure 2: Sleep onset latency measurements across treatment groups indicate that valerian extract administration is associated with reduced time to fall asleep in the murine model. Dose-dependent trends suggest a potential sedative-hypnotic effect.]()

> Source: Kazim Sahin et al. "Impact of a Novel Valerian Extract on Sleep Quality, Relaxation, and GABA/Seroto." *Antioxidants (Basel, Switzerland)*, 2024. PMID: [38929096](https://pubmed.ncbi.nlm.nih.gov/38929096/)
<figure>
  <img src="" alt="Sleep onset latency measurements across treatment groups indicate that valerian extract administration is associated with reduced time to fall asleep in the murine model. Dose-dependent trends suggest a potential sedative-hypnotic effect." />
  <figcaption>Figure 2. Sleep onset latency measurements across treatment groups indicate that valerian extract administration is associated with reduced time to fall asleep in the murine model. Dose-dependent trends suggest a potential sedative-hypnotic effect.<br>  Source: Kazim Sahin et al. "Impact of a Novel Valerian Extract on Sleep Quality, Relaxation, and GABA/Seroto." <em>Antioxidants (Basel, Switzerland)</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38929096/">38929096</a></figcaption>
</figure>